GLP-1 drugs spiked in popularity and price over the past few years, leaving the door open for illegal pharmacies to try and ...

More than three years after Novartis’ plan for a speedy approval for intrathecal Zolgensma was thwarted by an FDA requirement ...

A comprehensive lifestyle-improvement program -- delivered entirely online -- helped patients with inflammatory arthritis (IA ...

Varshavski: It is hard, but it is very important because when you have excess adipose skin tissue, that's a place where bacteria can live and fungi can live. Therefore, you can actually develop skin ...

More than 640,000 Massachusetts patients had medical information stole or exposed in breaches in 2024. Here's a searchable ...

The latest weekly report from the Arkansas Department of Health shows flu activity is increasing significantly in the state.

What new medicines are poised to take the leap from breakthrough to approval in 2025? Here’s what to expect this year.

Neumora Therapeutics' lead candidate, navacaprant, failed to meet primary and secondary endpoints in its Phase 3 KOASTAL-1 ...

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS ...

Embarking on a weight loss journey isn’t just about shedding kilos—it’s a transformative experience that impacts your ...